TABLE 2:
Patient (No.) | Stage | Nodal Level | MR Imaging Time Points | Percentage Measurement Error, % |
---|---|---|---|---|
1 | N0 | None | 0* | None |
2 | N2c | L II/III | 4 | 14, 13, 11, 11 |
3 | N2b | R II | 5 | 2, 1, 3, 9, 31† |
4 | N2c | R II/III | 3 | 2, 7, 3 |
5 | N2c | R II/III | 3 | 1, 2, 10 |
6 | N2b | L II-IV | 4 | 1, 1, 3, 8 |
7 | N2c | R II/III | 3 | 14, 26‡, 4 |
8 | N2a | R II | 3 | 5, 1, 4 |
9 | N2b | R II | 4 | 4, 12, 0, 11 |
10 | N2b | R II/III | 2 | 3, 30† |
11 | N2a | L II | 3 | 4, 1, 1 |
12 | N3 | R II | 3 | 17, 16, 27* |
13 | N2b | R II | 3 | 3, 17, 17 |
14 | N2c | L II | 4 | 4, 16, 13, 19 |
15 | N3 | R I-V | 3 | 3, 7, 20 |
16 | N2b | R II | 3 | 4, 9, 37† |
17 | N2c | L II/III | 3 | 9, 6, 4 |
No nodal metastases.
Percentage measurement error was greater than 20% because of small absolute differences in the volume measurements of small lesions.
Percentage measurement error was greater than 20% because of inaccuracies in the volume measurements due to patient motion.